Blue Horizon International Therapeutic Sciences
BHI Therapeutic Sciences is an international biotechnology company specializing in regenerative medicine and stem cell therapies. Committed to providing advanced, safe, and affordable treatments, the company is engaged in research, clinical trials, and a global network of licensed clinics. They focus on innovative therapies backed by extensive safety and efficacy data, with ongoing FDA IND trials for stroke treatment. Their mission is to lead in medical innovation and bring the benefits of stem cell therapy to as many people as possible.
Industries
Nr. of Employees
small (1-50)
Blue Horizon International Therapeutic Sciences
Hackensack, New Jersey, United States, North America
Products
Topical formulations containing stem cell-conditioned medium–derived ingredient
Skincare product line formulated with an ingredient derived from stem cell–conditioned medium intended to support skin firmness and elasticity.
High-dose Wharton's jelly–derived cell therapy dosing protocol
Clinical dosing protocol based on expanded Wharton's jelly–derived mesenchymal cells at defined high-dose levels for investigational therapeutic use.
Topical formulations containing stem cell-conditioned medium–derived ingredient
Skincare product line formulated with an ingredient derived from stem cell–conditioned medium intended to support skin firmness and elasticity.
High-dose Wharton's jelly–derived cell therapy dosing protocol
Clinical dosing protocol based on expanded Wharton's jelly–derived mesenchymal cells at defined high-dose levels for investigational therapeutic use.
Services
Provision of cell therapy treatments and associated clinical protocols for indications including stroke, spinal cord injury, and traumatic brain injury delivered through licensed clinics.
Clinical services including hormone optimization, supplement protocols, chelation therapy, and adjunctive research protocols for age-related conditions.
Services supporting IND-stage and later-phase clinical trials including protocol development, regulatory engagement, and multi-site trial coordination.
Provision of cell therapy treatments and associated clinical protocols for indications including stroke, spinal cord injury, and traumatic brain injury delivered through licensed clinics.
Clinical services including hormone optimization, supplement protocols, chelation therapy, and adjunctive research protocols for age-related conditions.
Services supporting IND-stage and later-phase clinical trials including protocol development, regulatory engagement, and multi-site trial coordination.
Expertise Areas
- Clinical trial management for cell therapies
- Stem cell therapy development (autologous and allogeneic)
- Cell therapy manufacturing and bioprocessing
- Regulatory strategy for IND and BLA pathways
Key Technologies
- Mesenchymal stem cell culture and expansion (Wharton's jelly source)
- Stem cell-conditioned medium formulations
- Cell therapy dosing and formulation
- IND/BLA regulatory submission processes